Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q4 2017 (← Previous) (Next →)
Filing Date: Feb 14, 2018
Total Value: $830M (99.6% shares, 0.4% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARRAY BIOPHARMA INC | 8,686,498 | $111M | 13.4% | — | — | COM | 04269X105 |
| ANAB | ANAPTYSBIO INC | 594,397 | $59.87M | 7.2% | — | — | COM | 032724106 |
| — | BLUEPRINT MEDICINES CORP | 767,354 | $57.87M | 7.0% | — | — | COM | 09627Y109 |
| XOMA | XOMA CORP DEL | 1,502,800 | $53.5M | 6.4% | — | — | COM NEW | 98419J206 |
| — | CONCERT PHARMACEUTICALS INC | 1,969,789 | $50.96M | 6.1% | — | — | COM | 206022105 |
| CYTK | CYTOKINETICS INC | 5,721,888 | $46.63M | 5.6% | — | — | COM NEW | 23282W605 |
| — | CHEMOCENTRYX INC | 7,587,416 | $45.15M | 5.4% | — | — | COM | 16383L106 |
| — | BIOLINERX LTD | 25,995,575 | $28.34M | 3.4% | — | — | SPONSORED ADR | 09071M106 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3,233,618 | $28.33M | 3.4% | — | — | COM | 87164F105 |
| — | ARQULE INC | 16,436,912 | $27.12M | 3.3% | — | — | COM | 04269E107 |
| CTMX | CYTOMX THERAPEUTICS INC | 1,124,483 | $23.74M | 2.9% | — | — | COM | 23284F105 |
| — | CTI BIOPHARMA CORP | 8,596,357 | $23.04M | 2.8% | — | — | COM NEW | 12648L601 |
| KURA | KURA ONCOLOGY INC | 1,353,846 | $20.71M | 2.5% | — | — | COM | 50127T109 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 9,766,508 | $19.83M | 2.4% | — | — | COM | 45665G303 |
| — | PIERIS PHARMACEUTICALS INC | 2,623,562 | $19.81M | 2.4% | — | — | COM | 720795103 |
| — | ONCOMED PHARMACEUTICALS INC | 4,271,289 | $17.51M | 2.1% | — | — | COM | 68234X102 |
| — | REGULUS THERAPEUTICS INC | 13,974,249 | $14.53M | 1.8% | — | — | COM | 75915K101 |
| — | GTX INC DEL | 1,107,433 | $14.07M | 1.7% | — | — | COM NEW | 40052B207 |
| — | ERYTECH PHARMA | 625,000 | $13.76M | 1.7% | — | — | SPONSORED ADR | 29604W108 |
| — | VBI VACCINES INC | 3,100,000 | $13.24M | 1.6% | — | — | COM NEW | 91822J103 |
| — | FORWARD PHARMA A/S | 3,455,117 | $12.65M | 1.5% | — | — | SPONSORED ADR | 34986J105 |
| SPRO | SPERO THERAPEUTICS INC | 1,029,185 | $12.09M | 1.5% | — | — | COM | 84833T103 |
| — | CASCADIAN THERAPEUTICS INC | 3,133,224 | $11.59M | 1.4% | — | — | COM NEW | 14740B606 |
| — | SPRING BK PHARMACEUTICALS INC | 823,474 | $11.08M | 1.3% | — | — | COM | 849431101 |
| XENE | XENON PHARMACEUTICALS INC | 3,588,830 | $10.14M | 1.2% | — | — | COM | 98420N105 |
| — | GLYCOMIMETICS INC | 497,474 | $8.353M | 1.0% | — | — | COM | 38000Q102 |
| — | ALPINE IMMUNE SCIENCES INC | 675,759 | $7.569M | 0.9% | — | — | COM | 02083G100 |
| — | SUNESIS PHARMACEUTICALS INC | 2,043,196 | $7.539M | 0.9% | — | — | COM PAR | 867328700 |
| — | MOLECULAR TEMPLATES INC | 724,132 | $7.256M | 0.9% | — | — | COM | 608550109 |
| — | VERASTEM INC | 2,250,000 | $6.908M | 0.8% | — | — | COM | 92337C104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 294,117 | $6.118M | 0.7% | — | — | COM | 74366E102 |
| — | IMMUNE DESIGN CORP | 1,469,800 | $5.732M | 0.7% | — | — | COM | 45252L103 |
| — | TOCAGEN INC | 556,683 | $5.706M | 0.7% | — | — | COM | 888846102 |
| CRVS | CORVUS PHARMACEUTICALS INC | 459,396 | $4.759M | 0.6% | — | — | COM | 221015100 |
| — | ACHILLION PHARMACEUTICALS INC | 1,608,433 | $4.632M | 0.6% | — | — | COM | 00448Q201 |
| — | INTRA CELLULAR THERAPIES INC | 273,350 | $3.958M | 0.5% | — | — | COM | 46116X101 |
| — | OREXIGEN THERAPEUTICS INC | 10,000,000 | $3.55M | 0.4% | — | — | NOTE 2.750%12/0 | 686164AB0 |
| — | CONTRAFECT CORP | 3,500,000 | $3.535M | 0.4% | — | — | COM | 212326102 |
| — | VICAL INC | 1,409,444 | $2.579M | 0.3% | — | — | COM NEW | 925602203 |
| ANTH | ANTHERA PHARMACEUTICALS INC | 1,216,403 | $2.007M | 0.2% | — | — | COM | 03674U300 |
| — | PAIN THERAPEUTICS INC | 325,509 | $1.302M | 0.2% | — | — | COM NEW | 69562K506 |
| — | OREXIGEN THERAPEUTICS INC | 734,976 | $948K | 0.1% | — | — | COM NEW | 686164302 |
| — | LOXO ONCOLOGY INC | 4,386 | $369K | 0.0% | — | — | COM | 548862101 |